Shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.88 and traded as high as $0.97. Oxbridge Re shares last traded at $0.9624, with a volume of 18,273 shares trading hands.
Analysts Set New Price Targets
Separately, Weiss Ratings raised shares of Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Oxbridge Re presently has an average rating of “Sell”.
Check Out Our Latest Analysis on OXBR
Oxbridge Re Stock Performance
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its earnings results on Saturday, February 14th. The insurance provider reported $0.02 earnings per share (EPS) for the quarter. Oxbridge Re had a negative net margin of 76.47% and a negative return on equity of 33.33%. The firm had revenue of $0.58 million during the quarter.
Hedge Funds Weigh In On Oxbridge Re
Several large investors have recently made changes to their positions in OXBR. J.W. Cole Advisors Inc. acquired a new position in shares of Oxbridge Re in the 3rd quarter valued at $59,000. Virtu Financial LLC acquired a new position in Oxbridge Re during the third quarter worth $32,000. Henrickson Nauta Wealth Advisors Inc. raised its position in Oxbridge Re by 100.0% during the fourth quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock worth $185,000 after acquiring an additional 68,700 shares during the period. Finally, International Assets Investment Management LLC acquired a new position in Oxbridge Re during the fourth quarter worth $39,000. 5.64% of the stock is currently owned by institutional investors and hedge funds.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Recommended Stories
- Five stocks we like better than Oxbridge Re
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
